argus

3B BlackBio Dx Limited

NSE: 3BBLACKBIOINE994E010181,306 Cr

Timeline

Time (IST)TypeMEventSrc
29 Aug, 02:55 pm3B BlackBio Dx Ltd - 532067 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
13 Aug, 04:29 pm3B BlackBio Dx Ltd - 532067 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
13 Aug, 04:15 pm3B BlackBio Dx Ltd - 532067 - Unaudited Financial Results For The Quarter Ended 30Th June, 2026bse
13 Aug, 04:08 pm3B BlackBio Dx Ltd - 532067 - Board Meeting Outcome for Outcome Of Board Meetingbse
05 Aug, 02:06 pm3B BlackBio Dx Ltd - 532067 - Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The First Quarter Ended 30Th June, 2026.bse
09 Jul, 04:29 pm3B BlackBio Dx Ltd - 532067 - Intimation To The Holders Of Physical Securities To Furnish KYC Detailsbse
25 Jun, 05:42 pm3B BlackBio Dx Ltd - 532067 - Letter For Transfer Of Shares To Investor Education And Protection Fund (IEPF)bse
25 Jun, 01:50 pm3B BlackBio Dx Ltd - 532067 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011bse
25 Jun, 12:40 pm3B BlackBio Dx Ltd - 532067 - Disclosure Under Regulation 29(2) Of SEBI (SAST) Regulations, 2011bse
03 Jun, 06:32 pm3B BlackBio Dx Ltd - 532067 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
01 Jun, 06:25 pm3B BlackBio Dx Ltd - 532067 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
29 May, 04:14 pm3B BlackBio Dx Ltd - 532067 - Announcement under Regulation 30 (LODR)-Dividend Updatesbse
29 May, 04:13 pm3B BlackBio Dx Ltd - 532067 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
29 May, 03:57 pm3B BlackBio Dx Ltd - 532067 - Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended On 31St March, 2026bse
29 May, 03:43 pm3B BlackBio Dx Ltd - 532067 - Board Meeting Outcome for Outcome Of Board Meetingbse
22 May, 05:34 pm3B BlackBio Dx Ltd - 532067 - Compliances-Reg.24(A)-Annual Secretarial Compliancebse
20 May, 03:27 pm3B BlackBio Dx Ltd - 532067 - Board Meeting Intimation for Consideration And Approval Of Audited Financial Results (Standalone And Consolidated) For Quarter / Financial Year Ended 31St March, 2026 And To Discuss Matter Of Recommendation Of Dividend ,If Any, For Financial Year Ended 31St March, 2026bse
21 Apr, 05:18 pm3B BlackBio Dx Ltd - 532067 - Securities Of The Companies Permitted To Trade And Admitted To Dealings On The National Stock Exchangebse
15 Apr, 05:09 pm3B BlackBio Dx Ltd - 532067 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2bse
15 Apr, 05:03 pm3B BlackBio Dx Ltd - 532067 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2bse
14 Apr, 05:09 pm3B BlackBio Dx Ltd - 532067 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure Abse
04 Apr, 04:19 pm3B BlackBio Dx Ltd - 532067 - Disclosure Under Regulation 31(4) Of SEBI (SAST) Regulations, 2011bse
17 Mar, 05:12 pm3B BlackBio Dx Ltd - 532067 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
24 Feb, 03:42 pm3B BlackBio Dx Ltd - 532067 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
21 Feb, 02:58 pm3B BlackBio Dx Ltd - 532067 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
19 Feb, 01:52 pm3B BlackBio Dx Ltd - 532067 - Letter To Shareholders From CEObse
06 Feb, 04:29 pm3B BlackBio Dx Ltd - 532067 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
06 Feb, 04:17 pm3B BlackBio Dx Ltd - 532067 - Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2025bse
06 Feb, 04:10 pm3B BlackBio Dx Ltd - 532067 - Board Meeting Outcome for Outcome Of Board Meetingbse
30 Jan, 03:25 pm3B BlackBio Dx Ltd - 532067 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended On 31St December, 2025.bse
24 Dec, 05:39 pm3B BlackBio Dx Ltd - 532067 - Disclosure Under Regulation 29(2) Of SEBI (SAST) Regulations, 2011bse
24 Dec, 05:38 pm3B BlackBio Dx Ltd - 532067 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011bse
20 Dec, 02:31 pm3B BlackBio Dx Ltd - 532067 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
29 Nov, 04:09 pm3B BlackBio Dx Ltd - 532067 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
20 Nov, 04:29 pm3B BlackBio Dx Ltd - 532067 - Vigilance Awareness Week 2025bse
13 Nov, 05:05 pm3B BlackBio Dx Ltd - 532067 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
13 Nov, 04:59 pm3B BlackBio Dx Ltd - 532067 - Board Meeting Outcome for Outcome Of Board Meetingbse
13 Nov, 04:57 pm3B BlackBio Dx Ltd - 532067 - Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30Th September,2025bse
06 Nov, 03:21 pm3B BlackBio Dx Ltd - 532067 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September, 2025.bse
27 Sept, 04:51 pm3B BlackBio Dx Ltd - 532067 - Appointment Of Secretarial Auditor.bse
27 Sept, 04:48 pm3B BlackBio Dx Ltd - 532067 - Announcement under Regulation 30 (LODR)-Change in Managementbse
04 Sept, 05:29 pm3B BlackBio Dx Ltd - 532067 - Letters To Shareholdersbse
04 Sept, 04:54 pm3B BlackBio Dx Ltd - 532067 - Announcement under Regulation 30 (LODR)-Dividend Updatesbse
04 Sept, 04:52 pm3B BlackBio Dx Ltd - 532067 - Record Date And Date Of Book Closure For The Purpose Of Dividend And AGMbse
04 Sept, 04:38 pm3B BlackBio Dx Ltd - 532067 - Reg. 34 (1) Annual Report.bse
01 Sept, 04:35 pm3B BlackBio Dx Ltd - 532067 - Disclosure Under Regulation 30 Of SEBI (LODR)Regulations, 2015bse